Merck Makes Changes At Riverside Plant | April 25, 2011 Issue - Vol. 89 Issue 17 | Chemical & Engineering News
Volume 89 Issue 17 | p. 21 | Concentrates
Issue Date: April 25, 2011

Merck Makes Changes At Riverside Plant

Department: Business
Keywords: pharmaceuticals, manufacturing

Merck & Co. has told employees at its facility in Riverside, Pa., that it will cut back operations by the end of 2013. After being sold to PWRT Services in 2008, the plant became known as Cherokee Pharmaceuticals. Then, last summer, it was sold back to Merck after PWRT found the contract manufacturing business too challenging. Merck plans for the site to focus on producing the antibiotic ingredients imipenem, cilastatin, and ertapenem. Other product manufacturing and a third-party fermentation business will be outsourced or sold. It is not yet known to what extent jobs will be cut.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment